Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP254069.RAqr-WZpkVKjs0TEAdTVdMKpoB5RA-7KyC9Y0VkI0vySM130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254069.RAqr-WZpkVKjs0TEAdTVdMKpoB5RA-7KyC9Y0VkI0vySM130_provenance.
• NP173747.RAryET50TILoPkijiJGYgO3dNSye1npJVDTZwN_Sl3Thw130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173747.RAryET50TILoPkijiJGYgO3dNSye1npJVDTZwN_Sl3Thw130_provenance.
• NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286821.RAzyh6x3MMxCeI_fDy8f--x6UFJPh8PX9Atf4-NGc_NwE130_provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP498827.RAAzR-6BXlLPZqRhEyn1j78ABVtMWBoXOt42CjAC7XYYQ130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498827.RAAzR-6BXlLPZqRhEyn1j78ABVtMWBoXOt42CjAC7XYYQ130_provenance.
• NP498825.RATm7fgmCpUd8EneBMXPyJpMBNeJX4Q307yI4BnEB0y6w130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498825.RATm7fgmCpUd8EneBMXPyJpMBNeJX4Q307yI4BnEB0y6w130_provenance.
• NP498826.RARnLtV1R8upzfK6SLHxUWhGi3VOVNKtODr8kuj3Xpwik130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498826.RARnLtV1R8upzfK6SLHxUWhGi3VOVNKtODr8kuj3Xpwik130_provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP498828.RAsopV0FECtssyCiaHjBEcFzyWeMsNcAUOzA_8Q4XkneQ130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498828.RAsopV0FECtssyCiaHjBEcFzyWeMsNcAUOzA_8Q4XkneQ130_provenance.
• NP498824.RAL75eK-1uelcb3zBuRrZ1NAFQ6vDKMDzHVWoPLpa0YdQ130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498824.RAL75eK-1uelcb3zBuRrZ1NAFQ6vDKMDzHVWoPLpa0YdQ130_provenance.
• NP498830.RAIcqCZuXdb8rWYCmIWUdvdoeuOHDrL1KCRK9MDbByVrA130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498830.RAIcqCZuXdb8rWYCmIWUdvdoeuOHDrL1KCRK9MDbByVrA130_provenance.
• NP498831.RAM7SdgGZW8xkpTSCTIRMPdgyeOiKRcZfnTYE7DWyjM-I130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498831.RAM7SdgGZW8xkpTSCTIRMPdgyeOiKRcZfnTYE7DWyjM-I130_provenance.
• NP498829.RA3zs34CR8MyAjtc9z4ZC-SdmfQwTneSlxnBI0KxxemGA130_assertion description "[Women with family histories suggestive of an increased risk of ovarian carcinoma who have not had a deleterious BRCA1 or BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound and/or assessment of CA 125 levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498829.RA3zs34CR8MyAjtc9z4ZC-SdmfQwTneSlxnBI0KxxemGA130_provenance.